Reference
Colrat F, et al. Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review. Vaccine : 29 Jan 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.12.036
Rights and permissions
About this article
Cite this article
FLUZONE High Dose cost effective in adults aged ≥65 years. PharmacoEcon Outcomes News 872, 15 (2021). https://doi.org/10.1007/s40274-021-7488-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7488-3